Scarica l'app Stockscreener
2.61
0.77%
0.02
Dopo l'orario di chiusura:
2.68
0.07
+2.68%
Precedente Chiudi:
$2.59
Aprire:
$2.58
Volume 24 ore:
35,420
Relative Volume:
0.10
Capitalizzazione di mercato:
$2.33M
Reddito:
-
Utile/perdita netta:
$-6.39M
Rapporto P/E:
-3.8955
EPS:
-0.67
Flusso di cassa netto:
$-6.42M
1 W Prestazione:
-8.74%
1M Prestazione:
-26.69%
6M Prestazione:
-62.55%
1 anno Prestazione:
-84.25%
Intervallo 1D:
$2.5164
$2.6997
Intervallo di 1 settimana:
$2.5164
$2.89
Portata 52W:
$2.36
$29.00
Heartsciences Inc Stock (HSCS) Company Profile
Nome
Heartsciences Inc
Settore
Industria
Telefono
682-237-7781
Indirizzo
550 RESERVE ST, SUITE 360, SOUTHLAKE
Confronta HSCS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| HSCS | 2.61 | 2.33M | 0 | -6.39M | -6.42M | -0.67 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Heartsciences Inc Borsa (HSCS) Ultime notizie
HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement - The Manila Times
HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement - GlobeNewswire
HeartSciences Secures $125 Medicare Reimbursement for AI-ECG Tech, Awaits FDA Nod | HSCS Stock News - StockTitan
HeartSciences shareholders approve auditor and meeting adjournment - Investing.com India
HeartSciences shareholders approve auditor and meeting adjournment By Investing.com - Investing.com UK
Contrasting Heart Test Laboratories (NASDAQ:HSCS) and Bone Biologics (NASDAQ:BBLG) - Defense World
Heart Test Laboratories announces corporate name change to HeartSciences - Investing.com India
Heart Test Laboratories (NASDAQ:HSCS) Stock Price Down 10.9% – Time to Sell? - Defense World
HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit - The Manila Times
Mobile Cardiac Telemetry Systems Market Players In Latest Report - WhaTech
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.34% - MSN
Heart Test Laboratories, Inc. (NASDAQ:HSCS) Short Interest Update - Defense World
A new trading data show Heart Test Laboratories Inc. (HSCS) is showing positive returns. - SETE News
Heart Test Laboratories Inc. [HSCS] is -75.15% lower this YTD. Is it still time to buy? - The DBT News
3 Penny Stocks to Watch Now, 9/25/24 - MSN
"Nasdaq Stocks Set for Explosive Growth: BNZI, SEEL, PRSO, MSS, HSCS Revamp for Big Potential" - WICZ
Heart Test Laboratories Inc. (HSCS) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Is Heart Test Laboratories Inc. (HSCS) a good investment opportunity? - US Post News
Pre-market Movers: MSS, HSCS, BIVI, GBNY, LBRDK… - RTTNews
Insider’s View: Deciphering Heart Test Laboratories Inc. (HSCS)’s Financial Health Through Ratios - The Dwinnex
Heart Test Laboratories’ (HSCS) Buy Rating Reaffirmed at Ascendiant Capital Markets - Defense World
Heart Test Laboratories, Inc. (NASDAQ:HSCS) Short Interest Down 11.8% in August - Defense World
Heart Test (HSCS) Stock Gains After-Market Following Volatile Trading - Stocks Telegraph
Shares of HeartSciences get a bump from announcement of non-dilutive financing - Kursiv Media
Closing Bell Recap: Heart Test Laboratories Inc. (HSCS) Ends at 2.79, Reflecting a -1.06 Downturn - The Dwinnex
HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results - ForexTV.com
How analysts predict Heart Test Laboratories Inc. (HSCS) will perform this quarter? - US Post News
HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission - StockTitan
Heart Test Laboratories (NASDAQ:HSCS) Shares Down 13% - Defense World
HSCS stock touches 52-week low at $3.01 amid sharp annual decline - Investing.com Australia
Heart Test Laboratories, Inc. announced that it expects to receive $2.01 million in funding - Marketscreener.com
Heart Test Labs extends loan maturity to 2025 - Investing.com
Heart Test Laboratories (NASDAQ:HSCS) Stock Price Up 9.2% - Defense World
Heart Test Labs stock target cut by two thirds, maintains buy - Investing.com
HSCSHeart Test Laboratories, Inc. Latest Stock News & Market Updates - StockTitan
HeartSciences reports fiscal 2024 financial results - Medical Buyer
HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results - ForexTV.com
Heart Test announces MyoVista wavECG selected by Innovation Value Institute - TipRanks
Innovation Value Institute Analysis Demonstrates - GlobeNewswire
Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency - StockTitan
Heart Test Laboratories announces analysis on MyoVista wavECG potential - TipRanks
Heart Test Laboratories (NASDAQ:HSCS) Trading Down 1.8% - Defense World
HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare - GlobeNewswire
HeartSciences to Present at the LD Micro Invitational XIV Conference - WICZ
HeartSciences Adds Another International Patent To Its IP Portfolio - MPO-mag
HeartSciences Adds Another International Patent to its IP Portfolio - MPO-mag
Doctors Say Providence’s Sale of Its Hospitals’ Testing Labs Has Endangered Patients - Willamette Week
In the Green: Heart Test Laboratories Inc. (HSCS) Closes at 4.04, Up/Down -8.60 from Previous Day - The Dwinnex
HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction - BioSpace
- Invest Chronicle - The InvestChronicle
Heartsciences Inc Azioni (HSCS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
0.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):